跳至主要内容
临床试验/ISRCTN37346212
ISRCTN37346212已完成未知

The effect of a new synbiotic yoghurt NAR” (???) in metabolic syndrome: a randomized, double-blind, placebo-controlled study

Committee of Science of the Ministry of Science and Education of the Republic of Kazakhstan0 个研究点目标入组 180 人开始时间: 2017年10月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

2020 gut microbial analysis results in https://pubmed.ncbi.nlm.nih.gov/30056386/ (added 25/11/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. No history of the use of probiotics or antibiotics for 3 months
  • 2. Blood pressure: = 130/90 mmHg
  • 3. Raised fasting plasma glucose (FPG): >100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes
  • 4. Dyslipidemia TG: = 1.695 mmol/L; HDL-C = 0.9 mmol/L (male), = 1.0 mmol/L (female)
  • 5. Central obesity: waist:hip ratio > 0.90 (male); > 0.85 (female), or body mass index > 30 kg/m2

排除标准

  • 1. Acute illness or fever at the time of recruitment
  • 2. Positive for HIV, hepatitis B or C, or for human papillomavirus (HPV)
  • 3. Had anamnesis for surgery of the gastrointestinal tract, including any bowel resection
  • 4. Pregnant or breastfeeding
  • 5. Participants who had used the following medications during the last 6 months: antibiotics, antifungal, antiviral or antiparasitic drugs; corticosteroids; cytokines; commercial probiotics; or vaccines

研究者

发起方
Committee of Science of the Ministry of Science and Education of the Republic of Kazakhstan

相似试验